Impact of the Coronavirus Disease 2019 Pandemic on Outpatient Antibiotic Prescriptions in the United States
Deanna J. Buehrle, M. Hong Nguyen, Marilyn M. Wagener, Cornelius J. Clancy
Abstract
In April 2020, there were significant reductions in prescription fills of each of the 10 most prescribed outpatient antibiotics in the United States. Monthly azithromycin, amoxicillin-clavulanate, and levofloxacin fills did not rebound significantly from April through July 2020. Coronavirus disease 2019 had an immediate and sustained impact on US outpatient antibiotic prescribing.
Topics & Concepts
MedicineAzithromycinMedical prescriptionLevofloxacinPandemicAmoxicillinAntibioticsCoronavirus disease 2019 (COVID-19)CoronavirusMoxifloxacinDiseaseInternal medicineInfectious disease (medical specialty)PharmacologyMicrobiologyBiologyAntibiotic Use and ResistanceBacterial Identification and Susceptibility TestingAntibiotics Pharmacokinetics and Efficacy